Matthew Welsh, MD
Hand Surgery · Clermont, FLNPI 1528471422
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,330 of the $4,751 with a category attached, or 70.1%. Reel Surgical, Inc. accounts for 70.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $2,521 and has fallen 83.6% since, to $414 in 2025.
Across 42 payments — averaging $113.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reel Surgical, Inc.$3K
- Stryker$548
- Johnson & Johnson$176
- Smith+Nephew$97
- Bioventus LLC$89
- Anika Therapeutics, Inc.$73
- plus $437 from 14 others
What the payments were for
- Food & beverage$1,42030%
- Education$3,33070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reel Surgical, Inc. | 3 | $3,330 |
| Stryker | 8 | $548 |
| Johnson & Johnson(2 entities) | 5 | $176 |
| Smith+Nephew | 3 | $97 |
| Bioventus LLC | 2 | $89 |
| Anika Therapeutics, Inc. | 2 | $73 |
| Vertex | 3 | $72 |
| Skeletal Dynamics Inc | 1 | $52 |
| Acumed LLC | 1 | $48 |
| Endo USA, Inc. | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 2 | $39 |
| Merck | 1 | $37 |
| Pacira Therapeutics, Inc. | 2 | $34 |
| Innovation Technologies Inc | 1 | $25 |
| Davol Inc. | 1 | $24 |
| Acera Surgical, Inc. | 1 | $20 |
| Guard Medical Inc. | 1 | $17 |
| Heraeus Medical, LLC. | 1 | $13 |
| IBSA Pharma Inc. | 1 | $11 |
| Embody, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,751 in reported general payments places this provider in the 55th percentile of 173 hand surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 78 | $554 |
| Diclofenac Sodium | 26 | $403 |
| Tramadol Hcl | 142 | $298 |
| Meloxicam | 60 | $203 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $139 |
| Oxycodone Hcl | 18 | $55 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Clermont
- Jorge Orbay-CerratoMiami$12.5M
- Peter EvansStuart$525K
- Nirav GuptaOcala$491K
- Francisco RubioMiami$345K
- Justin ZumstegOrlando$133K
- Maria-Carolina Orbay AranMiami$108K
- Paul PatersonVero Beach$104K
- Helen Hui-ChouMiami$95K
- Philipp StreubelWeston$81K
- Roy CardosoCoral Gables$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.